1.0
Sep 18, 2013
Recommend
CEO approval
Business Outlook
Pros
Start up company, patient population served.
Cons
Technology is novel, but results are no better than current treatments. Culture is non-transparent. Management is lackluster at best especially at the sales/marketing level. Interviewing process is very long and drawn out. Device company? It's really a DME. Physicians extremely hesitant with product viability. Not trusting of Senior management.